Merck & Co (MRK)
$85.98
2.58 (2.91%)
MRK Stock Quote Delayed 15 Minutes
Previous Close
$85.98
Market Cap
231.31B
PE Ratio
148.24
EPS
0.58
Volume (Avg. Vol.)
14.27M
Day's Range
85.58 - 88.83
52-Week Range
72.05 - 92.64
Dividend & Yield
1.92 (2.23%)
MRK Stock Predictions, Articles, and Merck & Co News
A Recent FDA Approval Will Be Huge in Moving Amarin Stock
FDA approval of Vascepa in use for cardiovascular events just widened Amarin’s revenue potential. Amarin stock should have a banner 2020.
Dow Jones Today: Data Does It Again
Some solid consumer sentiment and spending reports boosted stocks to close the week, although gains were modest.
3 Big Stock Charts for Thursday: Merck, Anheuser-Busch InBev, and PPG Industries
Thursday's 3 big stock charts highlight 3 recent movers that could rally if broad market optimism continues.
Dow Jones Today: Struggling at the Highs
Some of today's malaise can be attributed to Alphabet (NASDAQ:GOOGL,GOOG), which declined following a disappointing earnings report issued yesterday after the market closed. The internet search giant reported earnings of $10.12 a share on revenue of $40.50 billion while analysts expected earnings of $12.42 on revenue of $40.32 billion.
Stock Market Today: Earnings, Fed Drive New Highs
The S&P 500 hit another new all-time high on Tuesday. Here's what happened in the stock market today to get it there.
Dow Jones Today: Fed Obliges, Stocks Don’t
A divided Federal Reserve is a new issue for investors to consider. Read more about what happened in the Dow Jones today.
3 Big Stock Charts for Monday: Merck, Facebook and Microsoft
The stock charts of MSFT, FB and MRK have earned a closer technical look as the new trading week kicks off.
Bristol-Myers Squibb Stock Has Upside — But Mind the Risks
Bristol-Myers Squibb stock touched a multi-year low last month. But the BMY stock price is cheap enough now to take on real risks.
Why Bristol-Myers Squibb Stock Is Stumbling Ahead of Earnings
Investors turned sour on BMY stock after the Celgene buyout. Will a solid Q2 earnings report change the sentiment for the better?
A Pairs Prescription for CVS Stock and Merck
Longstanding cycles in CVS Health and Merck are at risk of changing and offering profits to spread traders buying CVS stock and shorting MRK.
Friday’s Vital Data: Bed Bath & Beyond, CVS and Merck
Options trading was buzzing in Bed Bath & Beyond, CVS, and Merck on Thursday. Here are the metrics that matter moving forward.
3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
4 Drug Stocks Getting Smashed
Drug stocks are falling on fears of President Trump's next move on drug prices. Here's a look at the charts.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
